Please login to the form below

Not currently logged in
Email:
Password:

NICE

This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer

NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer

Picks up approval as a first-line treatment for advanced cancer. The UK’s National Institute for Health and Care Excellence (NICE) has recommended Merck KGaA and Pfizer’s immunotherapy Bavencio ... NICE’s positive recommendation also addresses the

Latest news

More from news
Approximately 388 fully matching, plus 825 partially matching documents found.

Latest Intelligence

  • Keep your audiences close Keep your audiences close

    Keeping our audiences close is an important part of this: unless it hits home with its intended audience, a creative campaign or innovative tactic is just a nice idea and not

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    In the UK, NHS England is collaborating with the National Institute for Health and Care Excellence (NICE) on a pilot project under which NHS England will evaluate and procure two AMR ... The NICE project is an important initiative but, needless to say,

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    Yet NICE and many other HTA bodies limit their assessment to the cost-effectiveness of treatments to health systems alone, so their methodologies are more likely to report negatively and reduce

  • Creating a culture where innovation thrives Creating a culture where innovation thrives

    Yes, we may wrap that media survey up in a bow with a nice slogan and a pretty logo, but it’s still a media survey just like the one we

  • Case study: OptiMiSe for MS nurses Case study: OptiMiSe for MS nurses

    OptiMiSe is an innovative meetings based learning journey developed in line with the NICE Quality Standards for MS and the Royal Pharmaceutical Society’s (RPS) four principles of medicines optimisation: ... As a result, more patients are receiving a

More from intelligence
Approximately 11 fully matching, plus 118 partially matching documents found.

Latest appointments

More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 47 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....

Infographics